BIOGEN INC. Costs and Expenses
BIOGEN INC. (BIIB) reported Costs and Expenses of $2.10 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-04-29
- BIOGEN INC. costs and expenses for the quarter ending 2026-03-31 was $2.10B, a 0.93% decline year-over-year.
- BIOGEN INC. costs and expenses for the quarter ending 2025-12-31 was $2.34B, a 7.96% increase year-over-year.
- BIOGEN INC. costs and expenses for the quarter ending 2025-09-30 was $1.98B, a 1.86% decline year-over-year.
- BIOGEN INC. costs and expenses for the quarter ending 2025-06-30 was $1.90B, a 7.66% increase year-over-year.
- BIOGEN INC. costs and expenses for fiscal 2025 was $8.33B, a 7.26% increase from fiscal 2024.
- BIOGEN INC. costs and expenses for fiscal 2024 was $7.77B, a 9.00% decline from fiscal 2023.
- BIOGEN INC. costs and expenses for fiscal 2023 was $8.54B, a 29.74% increase from fiscal 2022.
- BIOGEN INC. costs and expenses for fiscal 2022 was $6.58B, a 28.74% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $2.10B 10-Q · filed 2026-04-29 | $4.44B derived: sum of 2 quarters · filed 2026-04-29 | $6.41B derived: sum of 3 quarters · filed 2026-04-29 | $8.31B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $2.34B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.31B derived: sum of 2 quarters · filed 2026-02-06 | $6.21B derived: sum of 3 quarters · filed 2026-02-06 | $8.33B 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $1.98B 10-Q · filed 2025-10-30 | $3.88B derived: sum of 2 quarters · filed 2025-10-30 | $6.00B 10-Q · filed 2025-10-30 | $8.16B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $1.90B 10-Q · filed 2025-07-31 | $4.02B 10-Q · filed 2025-07-31 | $6.18B derived: sum of 3 quarters · filed 2026-04-29 | $8.20B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $2.12B 10-Q · filed 2026-04-29 | $4.28B derived: sum of 2 quarters · filed 2026-04-29 | $6.30B derived: sum of 3 quarters · filed 2026-04-29 | $8.06B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $2.16B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.18B derived: sum of 2 quarters · filed 2026-02-06 | $5.94B derived: sum of 3 quarters · filed 2026-02-06 | $7.77B 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $2.01B 10-Q · filed 2025-10-30 | $3.78B derived: sum of 2 quarters · filed 2025-10-30 | $5.61B 10-Q · filed 2025-10-30 | $7.70B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $1.77B 10-Q · filed 2025-07-31 | $3.59B 10-Q · filed 2025-07-31 | $5.69B derived: sum of 3 quarters · filed 2026-02-06 | $8.36B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $1.83B 10-Q · filed 2025-05-01 | $3.92B derived: sum of 2 quarters · filed 2026-02-06 | $6.59B derived: sum of 3 quarters · filed 2026-02-06 | $8.34B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $2.09B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.77B derived: sum of 2 quarters · filed 2026-02-06 | $6.51B derived: sum of 3 quarters · filed 2026-02-06 | $8.54B 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $2.67B 10-Q · filed 2024-10-30 | $4.42B derived: sum of 2 quarters · filed 2024-10-30 | $6.44B 10-Q · filed 2024-10-30 | $8.38B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $1.75B 10-Q · filed 2024-08-01 | $3.77B 10-Q · filed 2024-08-01 | $5.71B derived: sum of 3 quarters · filed 2025-02-12 | $6.85B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $2.02B 10-Q · filed 2024-04-24 | $3.96B derived: sum of 2 quarters · filed 2025-02-12 | $5.10B derived: sum of 3 quarters · filed 2025-02-12 | $6.42B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $1.94B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.08B derived: sum of 2 quarters · filed 2025-02-12 | $4.40B derived: sum of 3 quarters · filed 2025-02-12 | $6.58B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $1.14B 10-Q · filed 2023-11-08 | $2.46B derived: sum of 2 quarters · filed 2023-11-08 | $4.64B 10-Q · filed 2023-11-08 | $6.97B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $1.32B 10-Q · filed 2023-07-25 | $3.50B 10-Q · filed 2023-07-25 | $5.83B derived: sum of 3 quarters · filed 2024-02-14 | $8.32B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $2.18B 10-Q · filed 2023-04-25 | $1.92B 10-Q · filed 2022-05-03 | $4.51B derived: sum of 2 quarters · filed 2024-02-14 | $7.00B derived: sum of 3 quarters · filed 2024-02-14 | $9.19B derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | $2.33B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $4.82B derived: sum of 2 quarters · filed 2024-02-14 | $7.01B derived: sum of 3 quarters · filed 2024-02-14 | $9.24B 10-K · filed 2024-02-14 | $8.14B 10-K · filed 2022-02-03 | |||
| 2021-09-30 | $2.49B 10-Q · filed 2022-10-25 | $1.98B 10-Q · filed 2021-10-20 | $4.68B derived: sum of 2 quarters · filed 2022-10-25 | $6.91B 10-Q · filed 2022-10-25 | $5.99B 10-Q · filed 2021-10-20 | $9.09B derived: sum of 4 quarters · filed 2023-02-15 | ||
| 2021-06-30 | $2.19B 10-Q · filed 2022-07-20 | $2.29B 10-Q · filed 2021-07-22 | $4.42B 10-Q · filed 2022-07-20 | $4.01B 10-Q · filed 2021-07-22 | $6.60B derived: sum of 3 quarters · filed 2023-02-15 | $8.89B derived: sum of 4 quarters · filed 2023-02-15 | ||
| 2021-03-31 | $1.72B 10-Q · filed 2022-05-03 | $4.41B derived: sum of 2 quarters · filed 2023-02-15 | $6.70B derived: sum of 3 quarters · filed 2023-02-15 | $8.40B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $2.69B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $4.98B derived: sum of 2 quarters · filed 2023-02-15 | $6.68B derived: sum of 3 quarters · filed 2023-02-15 | $8.40B 10-K · filed 2023-02-15 | $8.89B 10-K · filed 2021-02-03 | |||
| 2020-09-30 | $2.29B 10-Q · filed 2021-10-20 | $4.00B derived: sum of 2 quarters · filed 2021-10-20 | $5.71B 10-Q · filed 2021-10-20 | $7.60B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $1.71B 10-Q · filed 2021-07-22 | $3.42B 10-Q · filed 2021-07-22 | $5.32B derived: sum of 3 quarters · filed 2022-02-03 | $7.11B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $1.71B 10-Q · filed 2021-04-22 | $3.61B derived: sum of 2 quarters · filed 2022-02-03 | $5.40B derived: sum of 3 quarters · filed 2022-02-03 | $7.06B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $1.89B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $3.69B derived: sum of 2 quarters · filed 2022-02-03 | $5.35B derived: sum of 3 quarters · filed 2022-02-03 | $7.34B 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $1.79B 10-Q · filed 2020-10-21 | $3.45B derived: sum of 2 quarters · filed 2020-10-21 | $5.44B 10-Q · filed 2020-10-21 | $7.52B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $1.66B 10-Q · filed 2020-07-22 | $3.65B 10-Q · filed 2020-07-22 | $5.73B derived: sum of 3 quarters · filed 2021-02-03 | $7.47B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $1.99B 10-Q · filed 2020-04-23 | $4.07B derived: sum of 2 quarters · filed 2021-02-03 | $5.81B derived: sum of 3 quarters · filed 2021-02-03 | $7.96B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $2.08B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $3.82B derived: sum of 2 quarters · filed 2021-02-03 | $5.97B derived: sum of 3 quarters · filed 2021-02-03 | $7.56B 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $1.74B 10-Q · filed 2019-10-22 | $3.88B derived: sum of 2 quarters · filed 2019-10-22 | $5.48B 10-Q · filed 2019-10-22 | $7.32B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $2.14B 10-Q · filed 2019-07-24 | $3.74B 10-Q · filed 2019-07-24 | $5.58B derived: sum of 3 quarters · filed 2020-02-06 | $7.00B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $1.60B 10-Q · filed 2019-04-24 | $3.44B derived: sum of 2 quarters · filed 2020-02-06 | $4.86B derived: sum of 3 quarters · filed 2020-02-06 | $6.74B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $3.26B derived: sum of 2 quarters · filed 2020-02-06 | $5.14B derived: sum of 3 quarters · filed 2020-02-06 | $6.93B 10-K · filed 2020-02-06 | $6.93B 10-K · filed 2018-02-01 | |||
| 2017-09-30 | $1.42B 10-Q · filed 2018-10-23 | $1.42B 10-Q · filed 2017-10-24 | $3.30B derived: sum of 2 quarters · filed 2018-10-23 | $5.09B 10-Q · filed 2018-10-23 | $5.09B 10-Q · filed 2017-10-24 | $7.07B derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-06-30 | $1.88B 10-Q · filed 2018-07-24 | $1.88B 10-Q · filed 2017-07-25 | $3.66B 10-Q · filed 2018-07-24 | $3.66B 10-Q · filed 2017-07-25 | $5.65B derived: sum of 3 quarters · filed 2019-02-06 | $7.18B derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-03-31 | $1.79B 10-Q · filed 2018-04-24 | $1.79B 10-Q · filed 2017-04-25 | $3.77B derived: sum of 2 quarters · filed 2019-02-06 | $5.30B derived: sum of 3 quarters · filed 2019-02-06 | $6.73B derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | $1.98B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $3.52B derived: sum of 2 quarters · filed 2019-02-06 | $4.95B derived: sum of 3 quarters · filed 2019-02-06 | $6.30B 10-K · filed 2019-02-06 | $6.30B 10-K · filed 2017-02-02 | |||
| 2016-09-30 | $1.53B 10-Q · filed 2017-10-24 | $2.96B derived: sum of 2 quarters · filed 2017-10-24 | $4.31B 10-Q · filed 2017-10-24 | $5.98B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $1.43B 10-Q · filed 2017-07-25 | $2.78B 10-Q · filed 2017-07-25 | $4.45B derived: sum of 3 quarters · filed 2018-02-01 | $5.86B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $1.35B 10-Q · filed 2017-04-25 | $3.02B derived: sum of 2 quarters · filed 2018-02-01 | $4.43B derived: sum of 3 quarters · filed 2018-02-01 | $5.78B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $1.67B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $3.08B derived: sum of 2 quarters · filed 2018-02-01 | $4.44B derived: sum of 3 quarters · filed 2018-02-01 | $5.87B 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $1.41B 10-Q · filed 2016-10-26 | $1.41B 10-Q · filed 2015-10-21 | $2.76B derived: sum of 2 quarters · filed 2016-10-26 | $4.20B 10-Q · filed 2016-10-26 | $4.20B 10-Q · filed 2015-10-21 | $5.69B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $1.36B 10-Q · filed 2016-07-21 | $1.36B 10-Q · filed 2015-07-24 | $2.80B 10-Q · filed 2016-07-21 | $2.80B 10-Q · filed 2015-07-24 | $4.28B derived: sum of 3 quarters · filed 2017-02-02 | $5.64B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $1.44B 10-Q · filed 2016-04-21 | $1.44B 10-Q · filed 2015-04-24 | $2.92B derived: sum of 2 quarters · filed 2017-02-02 | $4.29B derived: sum of 3 quarters · filed 2017-02-02 | $5.72B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $1.49B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $2.85B derived: sum of 2 quarters · filed 2017-02-02 | $4.29B derived: sum of 3 quarters · filed 2017-02-02 | $5.75B 10-K · filed 2017-02-02 | $5.75B 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $1.36B 10-Q · filed 2015-10-21 | $2.80B derived: sum of 2 quarters · filed 2015-10-21 | $4.26B 10-Q · filed 2015-10-21 | $5.58B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $1.44B 10-Q · filed 2015-07-24 | $2.90B 10-Q · filed 2015-07-24 | $4.21B derived: sum of 3 quarters · filed 2016-02-03 | $5.36B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $1.46B 10-Q · filed 2015-04-24 | $2.78B derived: sum of 2 quarters · filed 2016-02-03 | $3.93B derived: sum of 3 quarters · filed 2016-02-03 | $4.99B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $1.32B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $2.47B derived: sum of 2 quarters · filed 2016-02-03 | $3.53B derived: sum of 3 quarters · filed 2016-02-03 | $4.44B 10-K · filed 2016-02-03 | $4.44B 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $1.15B 10-Q · filed 2014-10-22 | $2.22B derived: sum of 2 quarters · filed 2014-10-22 | $3.13B 10-Q · filed 2014-10-22 | $4.11B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $1.07B 10-Q · filed 2014-07-23 | $1.98B 10-Q · filed 2014-07-23 | $2.96B derived: sum of 3 quarters · filed 2015-02-04 | $3.85B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $909.62M 10-Q · filed 2014-04-23 | $1.90B derived: sum of 2 quarters · filed 2015-02-04 | $2.78B derived: sum of 3 quarters · filed 2015-02-04 | $3.69B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $987.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $1.87B derived: sum of 2 quarters · filed 2015-02-04 | $2.78B derived: sum of 3 quarters · filed 2015-02-04 | $3.71B 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $882.02M 10-Q · filed 2013-10-28 | $1.80B derived: sum of 2 quarters · filed 2013-10-28 | $2.72B 10-Q · filed 2013-10-28 | $3.64B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $915.23M 10-Q · filed 2013-07-25 | $1.84B 10-Q · filed 2013-07-25 | $2.76B derived: sum of 3 quarters · filed 2014-02-06 | $3.58B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $922.64M 10-Q · filed 2013-04-25 | $1.84B derived: sum of 2 quarters · filed 2014-02-06 | $2.66B derived: sum of 3 quarters · filed 2014-02-06 | $3.46B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $917.61M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $1.74B derived: sum of 2 quarters · filed 2014-02-06 | $2.54B derived: sum of 3 quarters · filed 2014-02-06 | $3.32B 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $821.44M 10-Q · filed 2012-10-25 | $1.62B derived: sum of 2 quarters · filed 2012-10-25 | $2.41B 10-Q · filed 2012-10-25 | $3.27B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $797.83M 10-Q · filed 2012-07-24 | $1.58B 10-Q · filed 2012-07-24 | $2.45B derived: sum of 3 quarters · filed 2013-02-05 | $3.43B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $787.06M 10-Q · filed 2012-05-01 | $1.65B derived: sum of 2 quarters · filed 2013-02-05 | $2.63B derived: sum of 3 quarters · filed 2013-02-05 | $3.45B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $863.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $1.85B derived: sum of 2 quarters · filed 2013-02-05 | $2.66B derived: sum of 3 quarters · filed 2013-02-05 | $3.47B 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $981.65M 10-Q · filed 2011-10-28 | $1.80B derived: sum of 2 quarters · filed 2011-10-28 | $2.60B 10-Q · filed 2011-10-28 | $3.35B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $816.82M 10-Q · filed 2011-07-26 | $1.62B 10-Q · filed 2011-07-26 | $2.37B derived: sum of 3 quarters · filed 2012-02-03 | $3.10B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $805.17M 10-Q · filed 2011-04-21 | $1.55B derived: sum of 2 quarters · filed 2012-02-03 | $2.29B derived: sum of 3 quarters · filed 2012-02-03 | $3.16B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $743.68M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $1.48B derived: sum of 2 quarters · filed 2012-02-03 | $2.35B derived: sum of 3 quarters · filed 2012-02-03 | $3.08B 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $736.34M 10-Q · filed 2010-10-26 | $1.61B derived: sum of 2 quarters · filed 2010-10-26 | $2.34B 10-Q · filed 2010-10-26 | $3.08B derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $870.38M 10-Q · filed 2010-07-20 | $1.60B 10-Q · filed 2010-07-20 | $2.35B derived: sum of 3 quarters · filed 2011-02-04 | $3.09B derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | $731.53M 10-Q · filed 2010-04-20 | $1.48B derived: sum of 2 quarters · filed 2011-02-04 | $2.22B derived: sum of 3 quarters · filed 2011-02-04 | $2.92B derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | $743.95M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $1.49B derived: sum of 2 quarters · filed 2011-02-04 | $2.19B derived: sum of 3 quarters · filed 2011-02-04 | $2.88B 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $747.11M 10-Q · filed 2009-10-21 | $1.44B derived: sum of 2 quarters · filed 2009-10-21 | $2.14B 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $696.65M 10-Q · filed 2009-07-17 | $1.39B 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $2.39B 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |